[Type 1 diabetes developing during alpha-interferon therapy: report of two cases]

MeSH terms

• Adult
• Antiviral Agents / administration & dosage
• Antiviral Agents / adverse effects*
• Antiviral Agents / therapeutic use
• Autoantibodies / immunology
• Autoimmune Diseases / chemically induced*
• Diabetes Mellitus, Type 1 / chemically induced*
• Drug Therapy, Combination
• Female
• Glutamate Decarboxylase / immunology
• Hepatitis C, Chronic / complications
• Hepatitis C, Chronic / drug therapy
• Humans
• Interferon alpha-2
• Interferon-alpha / administration & dosage
• Interferon-alpha / adverse effects*
• Interferon-alpha / therapeutic use
• Middle Aged
• Polyethylene Glycols / administration & dosage
• Polyethylene Glycols / adverse effects*
• Polyethylene Glycols / therapeutic use
• Recombinant Proteins
• Ribavirin / administration & dosage
• Ribavirin / therapeutic use